BioMaxima S.A. (WSE:BMX)
9.58
-0.10 (-1.03%)
Jun 16, 2026, 3:44 PM CET
BioMaxima Revenue
In the year 2025, BioMaxima had annual revenue of 60.90M PLN with 15.24% growth. BioMaxima had revenue of 17.68M in the quarter ending December 31, 2025, with 11.28% growth.
Revenue
60.90M
Revenue Growth
+15.24%
P/S Ratio
0.67
Revenue / Employee
451.14K
Employees
135
Market Cap
40.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.90M | 8.05M | 15.24% |
| Dec 31, 2024 | 52.85M | 6.07M | 12.96% |
| Dec 31, 2023 | 46.79M | -97.08M | -67.48% |
| Dec 31, 2022 | 143.87M | 64.78M | 81.91% |
| Dec 31, 2021 | 79.09M | 17.81M | 29.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 794.94M |
| Voxel | 583.14M |
| Read-Gene | 16.54M |
| Sygnis | 13.02M |
| Pharmena | 1.61M |
| Nestmedic | 1.02M |